Biologists create anti-HIV antibody that shows increased potency
Using highly potent antibodies isolated from HIV-positive people, researchers have recently begun to identify ways to broadly neutralize the many possible subtypes of HIV. Now, a team led by biologists at ...
HIV & AIDS
Oct 27, 2011 |
5 / 5 (4) |
0
|
Better 'mousetrap' discovered in fruit flies might stop human cancer-driving kinase in its tracks
A seemingly obscure gene in the female fruit fly that is only active in cells that will become eggs has led researchers at the Stowers Institute for Medical Research to the discovery of a atypical protein ...
Cancer
Mar 13, 2013 |
5 / 5 (3) |
0
|
Researchers determine how antibody recognizes key sugars on HIV surface
HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The ...
HIV & AIDS
Nov 23, 2011 |
5 / 5 (2) |
0
|
New findings on glucagon synthesis
Researchers at Karolinska Institutet in Sweden have shown that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin. ...
Medical research
Dec 03, 2012 |
5 / 5 (2) |
0
|
One drug, many targets: Finding molecular targets of an HIV drug used in cancer therapy
Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why ...
Medications
Apr 28, 2011 |
5 / 5 (1) |
0
|
From protein signaling to cancer drug development
(Medical Xpress)—Living organisms depend on proteins for their survival. These large, complex molecules mediate nearly every life function, but when the genes that code for them start to mutate, ...
Cancer
Jan 08, 2013 |
5 / 5 (1) |
0
'Traffic' in our cells works both for and against us
A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from ...
Medical research
May 01, 2013 |
5 / 5 (1) |
0
|
